According to Wave Life Sciences's latest financial reports and stock price the company's current Operating Margin is -101.93%. At the end of 2024 the company had an Operating Margin of -101.94%.
Year | Operating Margin | Change |
---|---|---|
2024 | -101.94% | 69.87% |
2023 | -60.01% | -98.65% |
2022 | -4,459.30% | 1338.17% |
2021 | -310.07% | -59.41% |
2020 | -763.94% | -41.39% |
2019 | -1,303.37% | 17.77% |
2018 | -1,106.72% | -57.92% |
2017 | -2,630.13% | -48.45% |
2016 | -5,102.56% | -59.81% |
2015 | -12,696.05% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.